Iyuda Therapeutics
Owings Mills, US · Delaware corporation
Find your way into Iyuda Therapeutics
Sign up to see every warm intro you have to Iyuda Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Iyuda Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RT
Robert TennantChief Executive Officer
EF
Ephraim FuchsNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$4.5M disclosed across 5 rounds · 2023–2026
▶$600KraisedApr 2026 · 2 investors · BiotechnologyRule 506(b)
▶$600KraisedApr 2026 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert TennantExecutive Officer
- Ephraim FuchsDirector
- Offering amount
- $600K
- Amount sold
- $600K
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedJun 2025 · 3 investors · BiotechnologyRule 506(b)
▶$1.3MraisedJun 2025 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert TennantExecutive Officer
- Ephraim FuchsDirector
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$342.7KraisedSep 2023 · 4 investors · BiotechnologyRule 506(b)
▶$342.7KraisedSep 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert TennantExecutive Officer
- Ephraim FuchsDirector
- Offering amount
- $342.7K
- Amount sold
- $342.7K
- Minimum investment
- $12.4K
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$900KraisedSep 2023 · 1 investors · BiotechnologyRule 506(b)
▶$900KraisedSep 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert TennantExecutive Officer
- Ephraim FuchsDirector
- Offering amount
- $900K
- Amount sold
- $900K
- Minimum investment
- $900K
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedSep 2023 · 1 investors · BiotechnologyRule 506(b)
▶$1.4MraisedSep 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ephraim FuchsDirector
- Robert TennantExecutive Officer
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- Minimum investment
- $1.4M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Iyuda Therapeutics raised?
- Iyuda Therapeutics has disclosed $4.5M raised across 5 rounds.
- Where is Iyuda Therapeutics headquartered?
- Iyuda Therapeutics is headquartered in Owings Mills, US.